Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Vanderbeke

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Medizinische Klinik|February 14, 1975
[Pharmacokinetics after oral and intravenous administration of tetracycline compounds (author's transl)]T Dimmling, O Vanderbeke
Medizinische Klinik|September 17, 1976
[Statistics and comparative pharmacokinetics (author's transl)]H Immich, O Vanderbeke
Arzneimittel-Forschung|January 1, 1981
[Clinical results with the antimycotic agent ciclopiroxolamine (author's transl)]W Adam, H G Peil, C Savopoulos, et al.
Vnitrni Lekarstvi|March 1, 1979
[Smoking--one of the risk factors in the development of occlusive disease]V Puchmayer, W Schoop, E Jacob, et al.
American Journal of Veterinary Research|July 1, 1975
Method of collecting urine and comparative investigation of quantities excreted by cats and dogs after administration of furosemideP Klatt, R Muschaweck, W Bossaller, et al.
Vnitrni Lekarstvi|September 1, 1979
[Occupation as a risk factor in the development of obstructive disease]V Puchmayer, W Schoop, P Bartůnĕk, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|August 5, 1978
Plasma cortisol levels in normal volunteers receiving either betamethasone valerate or desoximetasone by topical applicationP A Bromley, F O Müller, J Malan, et al.
Clinical Pharmacology and Therapeutics|May 1, 1979
Single and divided doses of penbutololF O Müller, H K Hundt, P A Bromley, et al.
Vnitrni Lekarstvi|July 1, 1980
[Hypertension as a risk factor for the development of obstructive peripheral artery disease]V Puchmayer, W Schoop, R Cífková, et al.
British Journal of Clinical Pharmacology|January 1, 1979
Pharmacokinetics of single and multiple doses of clobazam in humansW Rupp, M Badian, O Christ, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Medizinische Klinik|February 14, 1975
[Pharmacokinetics after oral and intravenous administration of tetracycline compounds (author's transl)]T Dimmling, O Vanderbeke
Medizinische Klinik|September 17, 1976
[Statistics and comparative pharmacokinetics (author's transl)]H Immich, O Vanderbeke
Arzneimittel-Forschung|January 1, 1981
[Clinical results with the antimycotic agent ciclopiroxolamine (author's transl)]W Adam, H G Peil, C Savopoulos, et al.
Vnitrni Lekarstvi|March 1, 1979
[Smoking--one of the risk factors in the development of occlusive disease]V Puchmayer, W Schoop, E Jacob, et al.
American Journal of Veterinary Research|July 1, 1975
Method of collecting urine and comparative investigation of quantities excreted by cats and dogs after administration of furosemideP Klatt, R Muschaweck, W Bossaller, et al.
Vnitrni Lekarstvi|September 1, 1979
[Occupation as a risk factor in the development of obstructive disease]V Puchmayer, W Schoop, P Bartůnĕk, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|August 5, 1978
Plasma cortisol levels in normal volunteers receiving either betamethasone valerate or desoximetasone by topical applicationP A Bromley, F O Müller, J Malan, et al.
Clinical Pharmacology and Therapeutics|May 1, 1979
Single and divided doses of penbutololF O Müller, H K Hundt, P A Bromley, et al.
Vnitrni Lekarstvi|July 1, 1980
[Hypertension as a risk factor for the development of obstructive peripheral artery disease]V Puchmayer, W Schoop, R Cífková, et al.
British Journal of Clinical Pharmacology|January 1, 1979
Pharmacokinetics of single and multiple doses of clobazam in humansW Rupp, M Badian, O Christ, et al.
Pageof 2